摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[IrCl(bis(diphenylphosphino)methane)2] | 132939-91-4

中文名称
——
中文别名
——
英文名称
[IrCl(bis(diphenylphosphino)methane)2]
英文别名
{IrCl(dppm)2}
[IrCl(bis(diphenylphosphino)methane)2]化学式
CAS
132939-91-4
化学式
C50H44ClIrP4
mdl
——
分子量
996.467
InChiKey
FAYYSTRRNYTGPB-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.42
  • 重原子数:
    56.0
  • 可旋转键数:
    8.0
  • 环数:
    10.0
  • sp3杂化的碳原子比例:
    0.04
  • 拓扑面积:
    0.0
  • 氢给体数:
    0.0
  • 氢受体数:
    0.0

反应信息

  • 作为反应物:
    描述:
    [IrCl(bis(diphenylphosphino)methane)2]四氢呋喃 为溶剂, 生成 [IrRu(H)(CO)3(μ-CO)(bis(diphenylphosphino)methane)2]
    参考文献:
    名称:
    Dell'Anna, Maria Michela; Trepanier, Steven J.; McDonald, Robert, Organometallics, 2001, vol. 20, p. 88 - 99
    摘要:
    DOI:
  • 作为产物:
    描述:
    chloro(1,1-bis(diphenylphosphino)methane)(1,1-bis(diphenylphosphino)methanido)hydridoiridium(III) 以 二氯甲烷 为溶剂, 生成 [IrCl(bis(diphenylphosphino)methane)2]
    参考文献:
    名称:
    膦配体与铱配合物的反应导致C(sp 3)-H键活化
    摘要:
    用短咬合双官能N,P-供体配体1-苄基-2-咪唑基二苯基膦(Ph 2 PBnIm)处理[Ir 2(μ-Cl)2(coe)4 ](coe =环辛烯)导致氧化加成从苄基到金属的C(sp 3)-H键的化学键形成[IrHCl {Ph 2 P(CHPh)Im}(Ph 2 PBnIm)](1),已通过X射线研究对其进行了充分表征。相关的配体2-吡啶基二苯基膦(Ph 2 PPy)与[Ir 2(μ-Cl)2(coe)4 ]反应,得到单核铱(I)络合物[IrCl(Ph 2 PPy)2 ](2),其显示了P,N-螯合和P-配位的配体。博士的加成2 PBnIm至2产生的替换P-协调的Ph 2聚吡咯配体与苄基C-H键除了铱沿开始,得到[IrHCl {博士2 P(CHPh配合)进出口}(PH 2聚吡咯)。该结果表明[IrCl(Ph 2 PBnIm)(L)]类型的单核络合物(L = P,N-螯合配体)是经历CH键活化反应的活性物质。[Ir
    DOI:
    10.1021/om049142i
点击查看最新优质反应信息

文献信息

  • An iridium-mediated C–H activation/CO2-carboxylation reaction of 1,1-bisdiphenylphosphinomethane
    作者:Jens Langer、María José Fabra、Pilar García-Orduña、Fernando J. Lahoz、Helmar Görls、Luis A. Oro、Matthias Westerhausen
    DOI:10.1039/c0dt00230e
    日期:——
    The reaction of 1,1-bisdiphenylphosphinomethane (dppm, 4 eq.) with [IrCl(coe)2]2 results in a solvent dependent equilibrium from which the complexes [IrCl(dppm)(dppm-H)(H)] (1) and [Ir(dppm)2]Cl (2) were isolated. When 2 is dissolved in methanol, [IrCl(dppm)2(H)][OCH3] (4) is formed as dominant species in solution. The C–H activation reaction which leads to 1 and 4 can be suppressed by adding an additional
    的反应 1,1-双二苯基膦甲烷 (百万分之几,4 eq。)与 [IrCl(coe)2 ] 2 导致溶剂依赖性平衡,复合物[IrCl(DPPM)(DPPM-H)(高)](1)和[Ir(DPPM)2 ] Cl(2)被隔离。当2溶解在甲醇,[IrCl(DPPM)2(H)] [OCH 3 ](4)在溶液中形成为主要物质。可以通过添加额外的碳来抑制导致1和4的C–H活化反应。百万分之几 每个配体 中心导致形成 [Ir(DPPM)3 ] Cl(5)。如果反应百万分之几 和 [IrX(coe)2 ] 2 (X = ,I)在CO 2气氛下进行[[IrX(DPPM)(H)(Ph 2 P)2 C–COOH}](6:X =; 7:X = I)由CH活化/ CO 2羧化序列形成。的反应6用NH 4 PF收率[的IrCl(DPPM)2(H)] PF 6(10)。另外 化合物[Li(dme)2(DPPM-H)](3)和[Li(dme)(Ph
  • Unusual mixed-metal carbonate-bridged complexes via oxidation of a carbonyl ligand in [RhM(CO)4(Ph2PCH2PPh2)2] (M = Mn, Re) and [IrRe(CO)5(Ph2PCH2PPh2)2]
    作者:David M. Antonelli、Martin Cowie
    DOI:10.1021/om00053a020
    日期:1991.7
    The complexes [RhM(CO)4(dppm)2] (M = Mn (1), Re (2); dppm = Ph2PCH2PPh2) and [IrRe(CO)5(dppm)2] (3) react with molecular oxygen to give the corresponding carbonate complexes [RhM(CO)3(mu-CO3)(dppm)2] (M = Mn (4), Re (5)) and [IrRe(CO)3(mu-CO3)(dppm)2] (6). No intermediates were observed in these reactions even at -60-degrees-C. The X-ray structure determination of compound 4 shows that the carbonate ligand bridges the metals in a unique mu-2-eta-2 fashion in which one oxygen atom bridges the metals and another is also bound in Mn leaving one oxygen uncoordinated. Compound 4 crystallizes in the monoclinic space group C2/c with a = 35.591 (6) angstrom, b = 12.556 (3) angstrom, c = 25.277 (5) angstrom, beta = 116.46 (2)-degrees, V = 10112.8 angstrom 3, and Z = 8. The structure, which displays a 70:30 rotationally disordered ''RhMn(CO)3(mu-CO3)'' moiety, has refined to R = 0.079 and R(w) = 0.104 on the basis of 366 parameters refined and 2942 independent observations.
  • Diphosphine-bridged, heterobimetallic complexes containing iridium and osmium. Reversible orthometalation of a bridging bis(diphenylphosphino)methane group at the iridium center promoted by the adjacent osmium center
    作者:Robert W. Hilts、Roberta A. Franchuk、Martin Cowie
    DOI:10.1021/om00051a018
    日期:1991.5
    The compound (PPN)[HOs(CO)4] reacts readily with [IrCl(eta-2-dppm)2] (PPN+ = (Ph3P)2N+, dppm = Ph2PCH2PPh2) at ambient temperature, yielding the heterobinuclear complex [IrOs(H)2(CO)3(mu-2-eta-3-(o-C6H4)PhPCH2PPh2)(dppm)] (1), in which one phenyl group is ortho-metalated at the Ir center. Treatment of 1 with the electrophile sources HBF4.Et2O or [AuPPh3]BF4 reverses the ortho metalation to give the hydrido-bridged species, [IrOs(CO)3(mu-H)(mu-X)(dppm)2][BF4] (X = H (2), AuPPh3 (3)). Deprotonation of 2 with use of NaH regenerates compound 1. The AuPPh3 group in 3 is readily replaced by an iodo group in the reaction with I2 to give [IrOs(CO)3(mu-H)(mu-I)(dppm)][TBF4] (4). Under a CO atmosphere, compound 2 yields [IrOs(CO)5(dppm)2][BF4] (5), and reaction of 5 with Me3NO.2H2O results in loss of one carbonyl group from the Ir center to yield [IrOs(CO)4(dppm)2][BF4] (6). The structure of 5 has been determined by X-ray techniques. This compound crystallizes, together with 1.5 equiv of CH2Cl2, in monoclinic space group P2(1)/c, with cell parameters a = 12.063 (2) angstrom, b = 22.725 (3) angstrom, c = 22.050 (3) angstrom, beta = 101.66 (1)-degrees, V = 5920 angstrom-3, and Z = 4. The structure has refined to R = 0.043 and R(w) = 0.043 and R(w) = 0.063 on the basis 5515 unique observations with 444 parameters varied. Compound 5 has a trans-bridging arrangement of diphosphine ligands and has two carbonyls bound to Ir and three on Os. The carbonyl and phosphine arrangement on Os suggests a trigonal bipyramidal (TBP) arrangement characteristic of Os(0), which then forms a dative Os --> Ir bond to the Ir(+I) center, giving it a TBP geometry also. The Os-Ir separation of 2.9652 (4) angstrom is at the long end of the range expected for a normal single bond.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫